skip to Global Navigation Bar skip to main content


homeHome > About Us > Press Release > News

News

News Content
Daewoong Pharmaceutical attended ICAD 2018 and promoted benefit of Nabota
Date 2018-11-27 Hit 2209
list
News List
Prev Daewoong Pharmaceutical held NABOTA Symposium to commemorate first ever permit in advanced nation for domestic botulinum toxin
Next The clinical findings of Botulinum Toxin manufactured by Daewoong have been published on international journal regarding the comparison with Botox